{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:36:00Z","timestamp":1792672560956,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100017594","name":"Medical Science and Technology Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2022RC009"],"award-info":[{"award-number":["2022RC009"]}],"id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LY23H050005"],"award-info":[{"award-number":["LY23H050005"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81900692"],"award-info":[{"award-number":["81900692"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Integrative Medicine"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.joim.2025.09.001","type":"journal-article","created":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T00:19:08Z","timestamp":1757031548000},"page":"694-705","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Astragaloside IV delayed the epithelial\u2013mesenchymal transition in peritoneal fibrosis by inhibiting the activation of EGFR and PI3K-AKT pathways"],"prefix":"10.1016","volume":"23","author":[{"given":"Ying","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-ling","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-hui","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu-xi","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shui-yu","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-kun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan-quan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.joim.2025.09.001_b0005","first-page":"1540","article-title":"End-stage kidney disease doubles","volume":"327","author":"Kuehn","year":"2022","journal-title":"J Am Med Assoc"},{"issue":"2","key":"10.1016\/j.joim.2025.09.001_b0010","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nrneph.2016.181","article-title":"Changes in the worldwide epidemiology of peritoneal dialysis","volume":"13","author":"Li","year":"2017","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"10.1016\/j.joim.2025.09.001_b0015","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1053\/j.ajkd.2020.10.005","article-title":"A global accounting of kidney replacement therapy","volume":"77","author":"Shah","year":"2021","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.joim.2025.09.001_b0020","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/ndt\/gfaa216","article-title":"Bleeding risk of haemodialysis and peritoneal dialysis patients","volume":"36","author":"van Eck van der Sluijs","year":"2021","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1016\/j.joim.2025.09.001_b0025","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1053\/j.ajkd.2019.05.014","article-title":"Transfers to hemodialysis among US patients initiating renal replacement therapy with peritoneal dialysis","volume":"74","author":"McGill","year":"2019","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"10.1016\/j.joim.2025.09.001_b0030","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/s41581-020-0315-4","article-title":"The current and future landscape of dialysis","volume":"16","author":"Himmelfarb","year":"2020","journal-title":"Nat Rev Nephrol"},{"issue":"5","key":"10.1016\/j.joim.2025.09.001_b0035","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1093\/ndt\/gfy290","article-title":"Peritoneal dialysis after kidney transplant failure: a nationwide matched cohort study from the French Language Peritoneal Dialysis Registry (RDPLF)","volume":"34","author":"Benomar","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.joim.2025.09.001_b0040","doi-asserted-by":"crossref","first-page":"6072","DOI":"10.3389\/fimmu.2021.607204","article-title":"Mechanisms of peritoneal fibrosis: focus on immune cells\u2013peritoneal stroma interactions","volume":"12","author":"Terri","year":"2021","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.joim.2025.09.001_b0045","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/nm.3218","article-title":"Origin and function of myofibroblasts in kidney fibrosis","volume":"19","author":"LeBleu","year":"2013","journal-title":"Nat Med"},{"issue":"16","key":"10.1016\/j.joim.2025.09.001_b0050","first-page":"3543","article-title":"Molecular mechanisms underlying peritoneal EMT and fibrosis","volume":"20","author":"Strippoli","year":"2016","journal-title":"Stem Cells Int"},{"issue":"5","key":"10.1016\/j.joim.2025.09.001_b0055","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41581-023-00694-0","article-title":"Regulated cell death pathways in kidney disease","volume":"19","author":"Sanz","year":"2023","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"10.1016\/j.joim.2025.09.001_b0060","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000430332","article-title":"Effects of astragaloside IV against the TGF-\u03b21-induced epithelial-to-mesenchymal transition in peritoneal mesothelial cells by promoting Smad 7 expression","volume":"37","author":"Zhang","year":"2015","journal-title":"Cell Physiol Biochem"},{"issue":"3","key":"10.1016\/j.joim.2025.09.001_b0065","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s11255-012-0350-6","article-title":"Smad7 inhibits TGF-\u03b21-induced MCP-1 upregulation through a MAPK\/p38 pathway in rat peritoneal mesothelial cells","volume":"45","author":"Wang","year":"2013","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.joim.2025.09.001_b0070","article-title":"Treatment of peritoneal fibrosis: therapeutic prospects of bioactive agents from Astragalus membranaceus","volume":"15","author":"Huang","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.joim.2025.09.001_b0075","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1277284","article-title":"Efficacy and safety of Chinese medicine injections in combination with docetaxel and cisplatin for non-small cell lung cancer: a network meta-analysis","volume":"14","author":"Wen","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.joim.2025.09.001_b0080","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2024.1374114","article-title":"Effect of astragalus injection on left ventricular remodeling in HFmrEF: a systematic review and meta-analysis","volume":"11","author":"Han","year":"2024","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"10.1016\/j.joim.2025.09.001_b0085","first-page":"331","article-title":"Astragalus polysaccharides attenuate pulmonary fibrosis by inhibiting the epithelial\u2013mesenchymal transition and NF-\u03baB pathway activation","volume":"46","author":"Zhang","year":"2020","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.joim.2025.09.001_b0090","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.2147\/DDDT.S404710","article-title":"Integrating network pharmacology and experimental validation to explore the pharmacological mechanism of astragaloside IV in treating bleomycin-induced pulmonary fibrosis","volume":"17","author":"Yuan","year":"2023","journal-title":"Drug Des Devel Ther"},{"issue":"10","key":"10.1016\/j.joim.2025.09.001_b0095","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1007\/s10620-019-06017-3","article-title":"Astragaloside IV synergizes with ferulic acid to alleviate hepatic fibrosis in bile duct-ligated cirrhotic rats","volume":"65","author":"Zhao","year":"2020","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.joim.2025.09.001_b0100","doi-asserted-by":"crossref","first-page":"6050","DOI":"10.3389\/fphar.2020.605064","article-title":"Astragaloside IV improves high-fat diet-induced hepatic steatosis in nonalcoholic fatty liver disease rats by regulating inflammatory factors level via TLR4\/NF-\u03baB signaling pathway","volume":"11","author":"Liu","year":"2021","journal-title":"Front Pharmacol"},{"issue":"19","key":"10.1016\/j.joim.2025.09.001_b0105","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1111\/jcmm.17871","article-title":"Astragaloside IV ameliorates peritoneal fibrosis by promoting PGC-1\u03b1 to reduce apoptosis in vitro and in vivo","volume":"27","author":"Xie","year":"2023","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.joim.2025.09.001_b0110","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1758-2946-6-13","article-title":"TCMSP: a database of systems pharmacology for drug discovery from herbal medicines","volume":"6","author":"Ru","year":"2014","journal-title":"J Cheminform"},{"issue":"Web Server issue","key":"10.1016\/j.joim.2025.09.001_b0115","doi-asserted-by":"crossref","first-page":"W32","DOI":"10.1093\/nar\/gku293","article-title":"SwissTargetPrediction: a web server for target prediction of bioactive small molecules","volume":"42","author":"Gfeller","year":"2014","journal-title":"Nucleic Acids Res"},{"issue":"Database issue","key":"10.1016\/j.joim.2025.09.001_b0120","first-page":"D115","article-title":"UniProt: the Universal Protein knowledgebase","volume":"32","author":"Boeckmann","year":"2004","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.joim.2025.09.001_b0125","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1\u20132","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"issue":"16","key":"10.1016\/j.joim.2025.09.001_b0130","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/jcc.20291","article-title":"GROMACS: fast, flexible, and free","volume":"26","author":"Van Der Spoel","year":"2005","journal-title":"J Comput Chem"},{"issue":"16","key":"10.1016\/j.joim.2025.09.001_b0135","doi-asserted-by":"crossref","first-page":"8607","DOI":"10.3390\/ijms25168607","article-title":"Pathophysiological mechanisms of peritoneal fibrosis and peritoneal membrane dysfunction in peritoneal dialysis","volume":"25","author":"Ito","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.joim.2025.09.001_b0140","doi-asserted-by":"crossref","first-page":"117833","DOI":"10.1016\/j.lfs.2020.117833","article-title":"Effect of oleuropein on oxidative stress, inflammation and apoptosis induced by ischemia\u2013reperfusion injury in rat kidney","volume":"255","author":"Nasrallah","year":"2020","journal-title":"Life Sci"},{"issue":"1","key":"10.1016\/j.joim.2025.09.001_b0145","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abd4639","article-title":"Soft implantable drug delivery device integrated wirelessly with wearable devices to treat fatal seizures","volume":"7","author":"Joo","year":"2021","journal-title":"Sci Adv"},{"issue":"11","key":"10.1016\/j.joim.2025.09.001_b0150","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.tips.2021.08.005","article-title":"Nanocarriers for oral delivery of biologics: small carriers for big payloads","volume":"42","author":"Cao","year":"2021","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.joim.2025.09.001_b0155","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.intimp.2023.110714","article-title":"The role of PI3K\/AKT signaling pathway in myocardial ischemia\u2013reperfusion injury","volume":"123","author":"Deng","year":"2023","journal-title":"Int Immunopharmacol"},{"issue":"8","key":"10.1016\/j.joim.2025.09.001_b0160","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1007\/s11255-024-03989-8","article-title":"The role of PI3K\/Akt signaling pathway in chronic kidney disease","volume":"56","author":"Wang","year":"2024","journal-title":"Int Urol Nephrol"},{"issue":"11","key":"10.1016\/j.joim.2025.09.001_b0165","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.1007\/s11010-021-04219-w","article-title":"Role of PI3K\/Akt signaling pathway in cardiac fibrosis","volume":"476","author":"Qin","year":"2021","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.joim.2025.09.001_b0170","article-title":"Pharmacologic inhibition of histone deacetylase 6 prevents the progression of chlorhexidine gluconate-induced peritoneal fibrosis by blockade of M2 macrophage polarization","volume":"13","author":"Shi","year":"2022","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.joim.2025.09.001_b0175","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.7150\/ijbs.77649","article-title":"Enhancement of zyxin promotes skin fibrosis by regulating FAK\/PI3K\/AKT and TGF-\u03b2 signaling pathways via integrins","volume":"19","author":"Huang","year":"2023","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.joim.2025.09.001_b0180","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.intimp.2016.11.006","article-title":"Astragaloside IV from Astragalus membranaceus ameliorates renal interstitial fibrosis by inhibiting inflammation via TLR4\/NF-\u043aB in vivo and in vitro","volume":"42","author":"Zhou","year":"2017","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"10.1016\/j.joim.2025.09.001_b0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1004924","article-title":"EGFR signal-network reconstruction demonstrates metabolic crosstalk in EMT","volume":"12","author":"Choudhary","year":"2016","journal-title":"PLoS Comput Biol"},{"issue":"1","key":"10.1016\/j.joim.2025.09.001_b0190","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s11658-024-00651-0","article-title":"Upregulation of ENAH by a PI3K\/AKT\/\u03b2-catenin cascade promotes oral cancer cell migration and growth via an ITGB5\/Src axis","volume":"29","author":"Chan","year":"2024","journal-title":"Cell Mol Biol Lett"},{"issue":"8","key":"10.1016\/j.joim.2025.09.001_b0195","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1073\/pnas.1018001108","article-title":"Feedback upregulation of HER3 (ErbB3) expression and activity attenuates antitumor effect of PI3K inhibitors","volume":"109","author":"Chakrabarty","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"10.1016\/j.joim.2025.09.001_b0200","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1158\/0008-5472.CAN-11-3747","article-title":"MEK inhibition leads to PI3K\/AKT activation by relieving a negative feedback on ERBB receptors","volume":"72","author":"Turke","year":"2012","journal-title":"Cancer Res"},{"issue":"7","key":"10.1016\/j.joim.2025.09.001_b0205","doi-asserted-by":"crossref","first-page":"104914","DOI":"10.1016\/j.jbc.2023.104914","article-title":"Allosteric inhibition of the epidermal growth factor receptor through disruption of transmembrane interactions","volume":"299","author":"Rybak","year":"2023","journal-title":"J Biol Chem"},{"key":"10.1016\/j.joim.2025.09.001_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116345","article-title":"Targeting EGFR degradation by autophagosome degraders","volume":"270","author":"Zhu","year":"2024","journal-title":"Eur J Med Chem"},{"issue":"1","key":"10.1016\/j.joim.2025.09.001_b0215","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/s12964-024-01678-8","article-title":"GLUT1 promotes cell proliferation via binds and stabilizes phosphorylated EGFR in lung adenocarcinoma","volume":"22","author":"Zhou","year":"2024","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.joim.2025.09.001_b0220","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cytogfr.2023.03.003","article-title":"Multiple post-translational modifications ensure EGFR functionality: potential therapeutic targets to overcome its drug-resistance mutations","volume":"70","author":"He","year":"2023","journal-title":"Cytokine Growth Factor Rev"},{"issue":"10","key":"10.1016\/j.joim.2025.09.001_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114812","article-title":"A MYC-STAMBPL1-TOE1 positive feedback loop mediates EGFR stability in hepatocellular carcinoma","volume":"43","author":"Zhang","year":"2024","journal-title":"Cell Rep"},{"issue":"10","key":"10.1016\/j.joim.2025.09.001_b0230","doi-asserted-by":"crossref","first-page":"815","DOI":"10.2174\/1568026620666200303123102","article-title":"Review on epidermal growth factor receptor (EGFR) structure, signaling pathways, interactions, and recent updates of EGFR inhibitors","volume":"20","author":"Sabbah","year":"2020","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.joim.2025.09.001_b0235","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.phrs.2018.11.014","article-title":"Small molecule inhibitors targeting the EGFR\/ErbB family of protein-tyrosine kinases in human cancers","volume":"139","author":"Roskoski","year":"2019","journal-title":"Pharmacol Res"}],"container-title":["Journal of Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095496425001372?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095496425001372?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T09:28:36Z","timestamp":1778837316000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2095496425001372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2095496425001372"],"URL":"https:\/\/doi.org\/10.1016\/j.joim.2025.09.001","relation":{},"ISSN":["2095-4964"],"issn-type":[{"value":"2095-4964","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Astragaloside IV delayed the epithelial\u2013mesenchymal transition in peritoneal fibrosis by inhibiting the activation of EGFR and PI3K-AKT pathways","name":"articletitle","label":"Article Title"},{"value":"Journal of Integrative Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joim.2025.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Shanghai Yueyang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}